Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Phenylacetic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis route for thyroid receptor agonist intermediates ensures high yield and supply chain stability for global pharmaceutical manufacturing partners.
Patent CN111170847B reveals a cyanide-free route for Drotaverine intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain safety.
Patent CN114133323B reveals a safe TMSCN-based route for morphine precursors, offering significant yield improvements and cost reduction in API manufacturing.
Novel U-shaped template strategy for meta-C-H olefination. Reduces steps and costs for API intermediates. High purity and scalability for pharmaceutical manufacturing.
Patent CN101417945A reveals a greener copper-catalyzed route for 4-bromo-2,3,5,6-tetrafluorophenylacetic acid, offering significant cost and safety advantages for pharmaceutical supply chains.
Patent CN102718659B enables high-yield synthesis of 4-bromo-2-nitrophenylacetic acid. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN101743218B reveals a superior resolution method for trans-2-aminocyclohexanol using 2-methoxyphenylacetic acid, offering high yield and cost-effective manufacturing for pharmaceutical intermediates.